Bradley Foster & Sargent Inc. CT Takes Position in Chemed Co. (NYSE:CHE)

Bradley Foster & Sargent Inc. CT acquired a new position in shares of Chemed Co. (NYSE:CHE) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 460 shares of the company’s stock, valued at approximately $250,000.

A number of other hedge funds have also recently added to or reduced their stakes in CHE. Rise Advisors LLC acquired a new position in Chemed in the first quarter valued at approximately $26,000. GAMMA Investing LLC grew its stake in Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after buying an additional 22 shares during the last quarter. Principal Securities Inc. acquired a new stake in Chemed in the fourth quarter worth $51,000. Mather Group LLC. bought a new stake in Chemed in the first quarter valued at $67,000. Finally, EntryPoint Capital LLC lifted its stake in Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after buying an additional 18 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Performance

Chemed stock opened at $582.06 on Friday. Chemed Co. has a one year low of $497.36 and a one year high of $654.62. The company has a 50-day simple moving average of $569.34 and a 200-day simple moving average of $578.05. The firm has a market capitalization of $8.81 billion, a P/E ratio of 31.33, a P/E/G ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The firm had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. Chemed’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter last year, the company posted $4.71 EPS. As a group, sell-side analysts forecast that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Monday, August 12th. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s payout ratio is 10.76%.

Insider Transactions at Chemed

In related news, EVP Nicholas Michael Westfall sold 1,713 shares of the company’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares of the company’s stock, valued at $3,478,159.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Chemed news, Director Andrea R. Lindell sold 831 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the completion of the transaction, the director now directly owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the sale, the executive vice president now directly owns 6,109 shares in the company, valued at approximately $3,478,159.15. The disclosure for this sale can be found here. Over the last quarter, insiders sold 6,744 shares of company stock valued at $3,828,231. 3.32% of the stock is currently owned by corporate insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.